Geneoscopy

Home - Geneoscopy - Transforming Gastrointestinal Health

St. Louis, United States · $218.9M raised

Employees
51–200
Business Model
B2B2C
Total Funding
$218.9M
Last Round
$105.0M Series CJan 2025
Rounds
5

About

Geneoscopy is a St. Louis-based life sciences company focused on developing noninvasive diagnostic tests for gastrointestinal health, including its FDA-approved ColoSense at-home stool RNA test for colorectal cancer screening. The company was co-founded by siblings Andrew Barnell (MBA) and Erica Barnell (MD/PhD) after Erica, during her medical training, encountered a Stage IV colorectal cancer patient who had never been screened due to the burden of traditional colonoscopy. Geneoscopy's proprietary multi-target stool RNA (mt-sRNA) biomarker panel aims to reduce screening barriers and close gaps in health equity for colorectal cancer detection.

Summary

Geneoscopy is a Biotech company based in St. Louis, United States. It has raised $218.9M in total across 5 rounds, most recently a $105.0M Series C round in Jan 2025. Investors include Cultivation Capital, NT Investments and Labcorp.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJan 2025
$105.0M

Sign up to see all 5 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Geneoscopy on Indexed.vc
<a href="https://indexed.vc/companies/geneoscopy"><img src="https://indexed.vc/api/badge/company/geneoscopy" alt="Geneoscopy on Indexed.vc" width="260" height="76" /></a>